Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer's Disease
Humanity is facing a vast prevalence of neurodegenerative diseases, with Alzheimer's disease (AD) being the most dominant, without efficacious drugs, and with only a few therapeutic targets identified. In this scenario, we aim to find molecular entities that modulate imidazoline I<sub>2&l...
Saved in:
Main Authors: | Andrea Bagán (Author), Sergio Rodriguez-Arévalo (Author), Teresa Taboada-Jara (Author), Christian Griñán-Ferré (Author), Mercè Pallàs (Author), Iria Brocos-Mosquera (Author), Luis F. Callado (Author), José A. Morales-García (Author), Belén Pérez (Author), Caridad Diaz (Author), Rosario Fernández-Godino (Author), Olga Genilloud (Author), Milan Beljkas (Author), Slavica Oljacic (Author), Katarina Nikolic (Author), Carmen Escolano (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Amelioration of BPSD-Like Phenotype and Cognitive Decline in SAMP8 Mice Model Accompanied by Molecular Changes after Treatment with I<sub>2</sub>-Imidazoline Receptor Ligand MCR5
by: Foteini Vasilopoulou, et al.
Published: (2020) -
Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer
by: Milan Beljkas, et al.
Published: (2023) -
Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design
by: Milan Beljkas, et al.
Published: (2024) -
Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy
by: Christian Griñán-Ferré, et al.
Published: (2024) -
3D-QSAR study and development of pharmacophore for serotonin 5-HT2A receptors agonists
by: Radan Milica, et al.
Published: (2017)